Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses.

@article{Resti1991FiveyearFO,
  title={Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses.},
  author={Massimo Resti and Chiara Azzari and M E Rossi and C Adami Lami and F Tucci and Alberto Vierucci},
  journal={Vaccine},
  year={1991},
  volume={9 1},
  pages={
          15-8
        }
}
The protective efficacy and long-term immunogenicity of a schedule with a reduced number of vaccinations in infants born to mothers positive for hepatitis B surface antigen (HBsAg) has been investigated: 494 infants immunized with a plasma derived hepatitis B vaccine (Hevac B Pasteur) at day 20 after birth and 2 months later were studied. Anti-HBs seroconversion rate was 96% after the second dose, a value similar to that obtained in older children. At 5 years of life anti-HBs at protective… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).

  • Canada communicable disease report = Releve des maladies transmissibles au Canada
  • 2000
VIEW 1 EXCERPT